Invesco S&P 500 Low Volatility ETF vs 22nd Century Group Inc — how do they compare? Invesco S&P 500 Low Volatility ETF trades at $75.64, while 22nd Century Group Inc trades at $4.46 (market cap $1.52M). The key difference: Invesco S&P 500 Low Volatility ETF is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals.
| SPLV | XXII | |
|---|---|---|
52-Week High | $77.97 | $801.00 |
52-Week Low | $70.30 | $3.72 |
Market Cap | — | $1.52M |
Sector | — | Technology |
Enterprise Value | — | -$6.71M |
Signals from Pluang's Aura AI — not financial advice
SPLV trades at $75.63, down slightly by 0.09% with a bullish technical signal supported by moving averages. The ETF maintains quarterly dividend payments of $0.14 and shows strong institutional interest amid market volatility concerns. Recent news highlights growing investor focus on low-volatility strategies as geopolitical tensions and AI bubble fears drive demand for stability-oriented investments.
The outlook remains positive as low-volatility ETFs gain traction during uncertain market conditions. Key opportunities include defensive positioning and consistent dividend income, while risks center on potential underperformance during strong bull markets and concentration in specific sectors. The ETF's historical resilience during downturns supports its defensive appeal.
No Aura AI signal available yet.
Trailing returns across standard periods
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the "index Provider") compiles, maintains and calculates the underlying index, which is designed to measure the performance of the 100 least volatile constituents of the S&P 500 ® Index over the past 12 months as determined by the index Provider.
Read more on SPLV →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →